Influx Healthtech Limited (NSE:INFLUX)
India flag India · Delayed Price · Currency is INR
275.50
-4.75 (-1.69%)
At close: Nov 16, 2026

Influx Healthtech Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
1,6551,4681,049999.65760.57592.02
Other Revenue
00----
1,6551,4681,049999.65760.57592.02
Revenue Growth
33.93%40.04%4.89%31.44%28.47%-
Cost of Revenue
1,011878.04639.48656.01528.63456.38
Gross Profit
644.06590.3409.05343.65231.94135.64
Selling, General & Admin
147.14132.36100.2982.2161.4539.8
Other Operating Expenses
161.19158.99102.0691.6163.2534.15
Operating Expenses
352.67329.13230.6192.36134.0875.16
Operating Income
291.39261.17178.46151.2897.8660.48
Interest Expense
-3.18-1.84-0.01-1.71-0.1-0.05
Interest & Investment Income
1.671.670.560.23--
Currency Exchange Gain (Loss)
0.070.07-0.220.01--
Other Non Operating Income (Expenses)
2.19-0-0.48-0.4-0.37
EBT Excluding Unusual Items
292.14261.06178.79149.3397.3660.06
Gain (Loss) on Sale of Investments
11.2511.25----
Pretax Income
303.38272.31178.79149.3397.3660.06
Income Tax Expense
7866.9245.1338.0525.415.69
Net Income
225.39205.39133.66111.2871.9644.37
Net Income to Common
225.39205.39133.66111.2871.9644.37
Net Income Growth
26.94%53.66%20.11%54.63%62.20%-
Shares Outstanding (Basic)
232218181818
Shares Outstanding (Diluted)
232218181818
Shares Change
18.72%21.06%---0.00%0.00%
EPS (Basic)
9.749.357.366.133.962.44
EPS (Diluted)
9.749.357.366.133.962.44
EPS Growth
6.97%27.01%20.06%54.80%62.00%-

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-229.36-206.75-11.555.8319.430.49
Free Cash Flow Per Share
-9.91-9.41-0.640.321.070.03
Gross Margin
38.92%40.20%39.01%34.38%30.50%22.91%
Operating Margin
17.61%17.79%17.02%15.13%12.87%10.22%
Profit Margin
13.62%13.99%12.75%11.13%9.46%7.49%
Free Cash Flow Margin
-13.86%-14.08%-1.10%0.58%2.55%0.08%
EBITDA
335.63298.85206.63169.74107.1961.7
EBITDA Margin
20.28%20.35%19.71%16.98%14.09%10.42%
D&A For EBITDA
44.2437.6828.1718.469.331.22
EBIT
291.39261.17178.46151.2897.8660.48
EBIT Margin
17.61%17.79%17.02%15.13%12.87%10.22%
Effective Tax Rate
25.71%24.57%25.24%25.48%26.09%26.13%
Revenue as Reported
1,6701,4821,0501,000760.57592.02
Advertising Expenses
-1.610.190.21.250.14